Baseline characteristics
In the surgical group, 99 eyes met the inclusion criteria, with 36 eyes completing the 3-month follow-up. In the non-surgical group, 39 eyes met the criteria, with 23 completing the follow-up. Baseline characteristics are detailed in Tables 1-4. The control group had lower UDVA than the surgical group, with no significant differences in age, AL, refractive error, CCT, and IOP. The control group also showed slightly higher nasal and temporal ARA250, temporal ARA750, and temporal TISA250, but these differences were not statistically significant. The surgical group had lower SVD, higher nasal RNFL thickness, and lower temporal RNFL thickness, with no significant differences in DVD, subfoveal CT, and superior/inferior RNFL thickness between the groups.
Table 1 Baseline characteristics in two groups
|
surgical group
|
non-surgery group
|
Age (years)
|
27.86±4.43
|
27.61±2.17
|
UDVA (logMAR)
|
1.23±0.27*
|
1.47±0.31*
|
Diopter (D)
|
-8.64±1.71
|
-8.58±1.38
|
AL (mm)
|
26.98±1.19
|
27.25±0.56
|
ACD (mm)
|
3.20±0.25
|
3.24±0.24
|
CCT (μm)
|
533.56±27.36
|
541.70±29.64
|
IOP (mmHg)
|
18.03±1.97
|
17.35±2.29
|
Values are expressed as mean ± standard deviation; *, P<0.05, **, P<0.01;
Table 2 Baseline characteristics of anterior chamber angle structures in 2 groups
|
surgical group
|
non-surgery group
|
|
nasal
|
temporal
|
nasal
|
temporal
|
AOD250 (mm)
|
0.47±0.20
|
0.50±0.21
|
0.55±0.28
|
0.65±0.32
|
AOD500 (mm)
|
0.72±0.28
|
0.75±0.27
|
0.78±0.33
|
0.91±0.36
|
AOD750 (mm)
|
0.99±0.32
|
1.01±0.32
|
0.98±0.32
|
1.19±0.35
|
ARA250 (mm²)
|
0.11±0.07*
|
0.13±0.07**
|
0.15±0.09*
|
0.19±0.11**
|
ARA500 (mm²)
|
0.26±0.13
|
0.29±0.13*
|
0.32±0.17
|
0.38±0.19*
|
ARA750 (mm²)
|
0.48±0.20
|
0.51±0.20*
|
0.55±0.25
|
0.65±0.27*
|
TISA250 (mm²)
|
0.09±0.04
|
0.10±0.05*
|
0.12±0.06
|
0.13±0.07*
|
TISA500 (mm²)
|
0.24±0.10
|
0.26±0.10
|
0.28±0.14
|
0.33±0.15
|
TISA750 (mm²)
|
0.46±0.17
|
0.48±0.18
|
0.51±0.22
|
0.60±0.24
|
TIA250 (°)
|
62.26±15.42
|
60.39±13.49
|
53.88±15.65
|
57.81±15.80
|
TIA500 (°)
|
55.08±11.78
|
54.31±10.82
|
50.14±13.14
|
54.09±13.38
|
TIA750 (°)
|
52.98±10.05
|
51.79±10.02
|
47.82±9.63
|
53.07±9.85
|
Values are expressed as mean ± standard deviation; *, P<0.05, **, P<0.01;
Table 3 Baseline SVD and DVD Characteristics in 2 Groups
(%)
|
surgical group
|
non-surgery group
|
|
SVD-whole image
|
44.25±3.63*
|
46.60±2.92*
|
|
SVD-whole image-SH
|
44.19±3.89*
|
46.62±3.35*
|
|
SVD-whole image-IH
|
44.34±3.61*
|
46.30±3.21*
|
|
SVD-fovea
|
18.16±7.27
|
20.82±4.60
|
|
SVD-parafovea
|
43.70±5.22*
|
46.88±3.80*
|
|
SVD-parafovea-SH
|
43.71±5.54*
|
46.94±4.45*
|
|
SVD-parafovea-IH
|
43.69±5.40
|
46.20±4.05
|
|
SVD-parafovea-T
|
44.33±5.78*
|
48.19±3.57*
|
|
SVD-parafovea-S
|
44.80±5.28*
|
47.83±4.93*
|
|
SVD-parafovea-N
|
41.31±6.86*
|
45.10±5.07*
|
|
SVD-parafovea-I
|
44.36±6.75
|
46.14±4.39
|
|
SVD-perifovea
|
45.48±3.65*
|
47.58±3.08*
|
|
SVD-perifovea-SH
|
45.33±3.99*
|
47.55±3.65*
|
|
SVD-perifovea-IH
|
45.64±3.63*
|
47.41±3.39*
|
|
SVD-perifovea-T
|
38.99±4.81
|
40.73±3.96
|
|
SVD-perifovea-S
|
45.97±4.47
|
48.06±4.04
|
|
SVD-perifovea-N
|
50.85±3.32*
|
52.95±3.39*
|
|
SVD-perifovea-I
|
46.17±4.32*
|
48.24±3.75*
|
|
DVD-whole image
|
42.03±5.23
|
42.11±4.13
|
DVD-whole image-SH
|
42.71±5.84
|
42.50±4.61
|
DVD-whole image-IH
|
41.33±5.01
|
42.28±5.06
|
DVD-fovea
|
36.02±7.51
|
36.00±6.50
|
DVD-parafovea
|
51.04±4.90
|
50.77±4.99
|
DVD-parafovea-SH
|
51.55±5.66
|
51.88±5.72
|
DVD-parafovea-IH
|
50.83±5.17
|
50.81±5.72
|
DVD-parafovea-T
|
52.91±6.24
|
53.51±5.32
|
DVD-parafovea-S
|
49.85±6.36
|
50.18±5.85
|
DVD-parafovea-N
|
53.00±3.92
|
52.91±5.58
|
DVD-parafovea-I
|
48.42±6.19
|
45.00±7.31
|
DVD-perifovea
|
41.95±5.90
|
42.10±4.72
|
DVD-perifovea-SH
|
43.29±6.61
|
43.05±5.80
|
DVD-perifovea-IH
|
40.60±5.88
|
41.86±5.45
|
DVD-perifovea-T
|
45.94±5.74
|
46.52±5.64
|
DVD-perifovea-S
|
42.08±7.61
|
51.22±6.45
|
DVD-perifovea-N
|
40.41±6.18
|
41.83±6.99
|
DVD-perifovea-I
|
39.32±6.18
|
40.27±5.60
|
Values are expressed as mean ± standard deviation; *, P<0.05, **, P<0.01;
Table 4 Baseline Characteristics of CT and RNFL Thickness Between Two Groups
|
surgical group
|
non-surgery group
|
CT (μm)
|
181.43±82.23
|
201.91±93.27
|
RNFL-S (μm)
|
121.00±18.70
|
114.78±10.95
|
RNFL-N (μm)
|
67.13±13.99**
|
60.74±9.24**
|
RNFL-T (μm)
|
82.04±13.47**
|
89.26±12.85**
|
RNFL-I (μm)
|
121.91±17.20
|
118.91±21.01
|
Values are expressed as mean ± standard deviation; *, P<0.05, **, P<0.01;
UDVA, IOP and refractive change at 3 months follow-up
The surgical group was assessed at 1 day, 1 week, and 3 months postoperatively for UDVA, IOP, and refractive power, as detailed in Table 5. UDVA significantly improved after ICL implantation (P<0.01). IOP increased at 1 day and 1 week postoperatively (P<0.05) but returned to preoperative levels by 3 months. Repeated measures analysis showed significant IOP fluctuations during follow-up (P<0.05). UDVA progressively improved from 1 day to 3 months (P<0.01), while IOP rose by approximately 4.4% and 9.7% at 1 day and 1 week, respectively, before normalizing at 3 months. The changes in IOP were not clinically significant and unrelated to time factors.
Table 5 Changes in UDVA, IOP and refractive error at 3 months postoperatively in the surgical group
|
Postoperative
|
1d
|
1w
|
3m
|
UDVA (logMAR)
|
1.23±0.27
|
0.02±0.06**
|
-0.03±0.08**
|
-0.07±0.06**
|
IOP (mmHg)
|
18.03±1.97
|
18.83±2.30*
|
19.79±3.02*
|
17.56±2.07
|
Diopter (D)
|
-8.64±1.71
|
0.44±0.50**
|
0.12±0.84**
|
0.07±0.25**
|
Values are expressed as mean ± standard deviation; *, P<0.05, **, P<0.01;
Table 6 UDVA, IOP and refractive change in the non-surgery group between 3-month follow-up
|
Baseline
|
3m
|
UDVA (logMAR)
|
1.47±0.31
|
1.47±0.31
|
IOP (mmHg)
|
17.35±2.29
|
16.91±2.09*
|
Diopter (D)
|
-8.57±1.38
|
-8.67±1.27
|
Values are expressed as mean ± standard deviation; *, P<0.05, **, P<0.01;
Changes in Anterior Chamber Angle Parameters in the Two Group
Postoperative AS-OCT assessments at 1 day, 1 week, 1 month, and 3 months revealed significant reductions in AOD, ARA, TISA, and TIA on both nasal and temporal sides compared to preoperative measures (Figure 5). By 3 months, nasal AOD750 and both nasal and temporal ARA values, especially ARA250 and ARA750, showed significant recovery (P < 0.05). TISA250 on the temporal side also slightly increased at 3 months compared to 1 week postoperatively, while TIA values decreased progressively until 3 months with no further decline. The non-surgery group showed no significant changes, indicating that the observed alterations in the surgical group are due to ICL implantation rather than high myopia.
Posterior Segment Structural Changes
Figure 6 shows the 3-month postoperative changes in SVD and DVD in the surgical group. Initially, SVD remained stable at 1 day postoperatively but significantly decreased in most areas by 1 week (P < 0.05), except in the macular region and nasal quadrant. By 3 months, SVD rebounded to preoperative levels, with notable increases in specific regions (P < 0.05). DVD decreased in certain areas at 1 week (P < 0.05) but significantly increased in the pericentral region by 3 months. By 3 months, DVD returned to preoperative levels across all regions. The non-surgery group showed no significant changes, suggesting the fluctuations in the surgical group are due to ICL implantation rather than high myopia.
Figure 7 shows changes in FAZ area, CT, RNFL, and DRVD within 3 months postoperatively in the surgical group. No significant changes were observed in the FAZ area or subfoveal CT after ICL implantation, though there was a slight decrease in CT at 3 months, warranting further study. The RNFL thickness in the superior and nasal regions decreased significantly by 1 day postoperatively (P<0.05), with a reduction of about 5.6μm in the superior RNFL and 10.3μm in the nasal RNFL. These reductions persisted without further significant changes at 1 week and 3 months. DRVD mildly increased on day 1 postoperatively but showed a significant decrease by 1 week, rebounding to preoperative levels by 3 months. The non-surgery group showed no changes in FAZ area, CT, RNFL, or DRVD during follow-up.
Correlation analysis of anterior chamber angle with posterior segment
In this study, Spearman correlation analysis identified several significant associations between postoperative changes. Notably, at 1-day post-surgery, SVD alterations in the pericentral recess region correlated positively with changes in nasal AOD750, nasal TIA750, and temporal TIA500. Furthermore, at 3 months post-surgery, superior hemispheric DVD changes showed a positive correlation with changes in nasal ARA250, nasal ARA500, and nasal TISA250.Conversely, at 1-day post-surgery, DVD changes in the nasal quadrant of the pericentral recess were negatively correlated with IOP changes, a relationship mirrored by the change in DRVD. At 1-week post-surgery, IOP changes were negatively correlated with DVD changes in the paracentral recess. At 3-months post-surgery, SVD changes in the inferior hemispheric region negatively correlated with changes in nasal AOD250, nasal ARA250, and nasal TISA250. Between 1 week and 3 months post-surgery, IOP changes negatively correlated with SVD changes, while SVD changes around the central recess showed a negative correlation with changes in nasal TIA250, nasal TIA500, and temporal TIA750. All correlations were statistically significant (p < 0.05).